Skip Navigation

Profile

Stephen B. Tatter, M.D., Ph.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

193 Ratings
15 Comments
 

Stephen B. Tatter, M.D., Ph.D.

Professor,

Clinical Interests

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor

Contact Information

Department: 336-716-4081

Insurance Accepted »

Media Medical Expert »

Related Links

Education & Training

  • B.S., University of Michigan/Ann Arbor, 1982
  • M.D., Cornell University Medical College, 1990
  • Ph.D., Rockefeller University, 1990
  • Residency, Surgery, Massachusetts Gen Hosp, 1996
  • Fellowship, Harvard Medical School, 1997

Board Certifications

  • American Board of Neurological Surgery, Neurological Surgery

Memberships

  • Nat'L Board Of Medical Examine
  • Neurosciences Society
  • North Carolina Neurosurgical S
  • Am Assn Of Neurological Surgeo
  • Soc Of University Neurosurgeon
  • Southern Neurosurgical Society
  • Congress Of Neurological Surge
  • Forsyth-Davie-Stokes Medical S

NPI Number

  • 1831178151
Stephen B. Tatter, M.D., Ph.D.

Doctor Rating

4.7 out of 5

193 Ratings
15 Comments
 

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery

Research Interests

Radiosurgery; Brain Neoplasms; Neoplasm Recurrence, Local; Glioma; Meningioma
More »

Contact Information

Academic: 336-716-4047 | Department: 336-716-4081

Media Medical Expert »

Related Links

Recent Publications

Emerging indications for fractionated gamma knife radiosurgery. McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2017;80(2):210-216.

Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Laxton AW, Tatter SB, Watabe K, Chan MD.. J Neurosurg. 2017;127(1):148-156.

Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. McTyre ER, Johnson AG, Ruiz J, Isom S, Lucas JT Jr, Hinson WH, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neuro Oncol. 2017;19(4):558-566.

Stereotactic radiosurgical treatment of glomus jugulare tumors. Winford TW, Dorton LH, Browne JD, Chan MD, Tatter SB, Oliver ER.. Otol Neurotol. 2017;38(4):555-562.

Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. Page BR, Wang EC, White L, McTyre E, Peiffer A, Alistar A, Mu F, Loganathan A, Bourland JD, Laxton AW, Tatter SB, Chan MD.. J Med Imaging Radiat Oncol. 2017;61(4):522-527.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide. McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD.. Am J Clin Oncol. 2017;():.

Laser thermal ablation for metastases failing radiosurgery: a multicentered retrospective study. Chaunzwa TL, Deng D, Leuthardt EC, Tatter SB, Mohammadi AM, Barnett GH, Chiang VL.. Neurosurgery. 2017;():.

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Sapan CV, Eidelberg D, During MJ,.. JCI Insight. 2017;2(7):e90133.

The effects of smoking status and smoking history on patients with brain metastases from lung cancer. Shenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, Laxton AW, Tatter SB, Warren GW, Chan MD.. Cancer Med. 2017;6(5):944-952.

Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. Wang EC, Huang AJ, Huang KE, McTyre ER, Lo HW, Watabe K, Metheny-Barlow L, Laxton AW, Tatter SB, Strowd RE, Chan MD, Page BR.. J Clin Neurosci. 2017;43():6-10.

Application of localized sub-atmospheric pressure to the brain and spinal cord. Morykwas MJ, Argenta LC, Tatter SB, inventors; Wake Forest University Health Sciences, assignee.. Israel patent IL 206899. 2017 Mar 30. 2017;():.

Device and method for treating central nervous system pathology. Argenta LC, Morykwas MJ, Tatter SB, inventors; Wake Forest University Health Sciences, assignee.. Australia patent AU 2.01E+09. 2017 Apr 20. 2017;():.

Surgical considerations in the optimal management of patients with malignant brain tumors. Renfrow JJ, Strowd RE, Laxton AW, Tatter SB, Geer CP, Lesser GJ.. Curr Treat Options Oncol. 2017;18(8):46.

Tolerability and initial efficacy of convection-enhanced delivery of combinatorial IL-13RA2 and EPHA2 targeted cytotoxins to dogs with spontaneous intracranial malignant gliomas [abstract]. Rossmeisl JH, Herpai D, Robertson JL, Dickinson PJ, Tatter SB, Debinski W.. Neuro Oncol. 2017;19(Suppl 3):56.

A single pharmaceutic agent for molecular resection of glioblastoma [abstract]. Sonawane P, Herpai D, Ferluga S, Tatter SB, Debinski W.. Neuro Oncol. 2017;19(Suppl 3):56.

Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram. Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT Jr, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, Kleinberg L, Shen C, Taylor RB, Onyeuku NE, Hyde AT, Gorovets D,.. J Neurooncol. 2017;135(2):403-411.

Stereotactic radiosurgery in the treatment of brain metastases from gynecologic primary cancer. Johnston H, McTyre ER, Cramer CK, Lesser GJ, Ruiz J, Bourland JD, Watabe K, Lo HW, Qasem S, Laxton AW, Tatter SB, Chan MD.. J Radiosurg SBRT. 2017;5(1):55-61.

Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes. Randolph DM, McTyre E, Klepin H, Peiffer AM, Ayala-Peacock D, Lester S, Laxton AW, Dohm A, Tatter SB, Shaw EG, Chan MD.. J Radiosurg SBRT. 2017;5(1):35-42.

Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: clinical outcomes and local control. Dohm A, McTyre ER, Chan MD, Fan C, Isom S, Bourland JD, Mott RT, Cramer CK, Tatter SB, Laxton AW.. J Clin Neurosci. 2017;46():90-98.

Staged stereotactic radiosurgery for large brain metastases: local control and clinical outcomes of a one-two punch technique. Dohm A, McTyre ER, Okoukoni C, Henson A, Cramer CK, LeCompte MC, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2017;():.

Clinical outcomes of upfront stereotactic radiosurgery alone for patients with greater than 4 brain metastases [abstract]. Hughes RT, McTyre E, LeCompte MC, Cramer CK, Munley MT, Laxton A, Tatter SB, Ruiz J, Pasche B, Watabe K, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E80-E81.

Survival and failure outcomes predicted by brain metastasis kinetics following initial distant brain failure in melanoma patients treated upfront with stereotactic radiosurgery alone [abstract]. LeCompte MC, McTyre E, Henson A, Farris M, Okoukoni C, Cramer CK, Triozzi P, Munley MT, Qasem S, Xing F, Watabe K, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E86-E87.

Drivers of the cost of management in patients treated with radiosurgery without whole brain radiation therapy for brain metastases [abstract]. Shenker RF, McTyre E, Cramer CK, Munley MT, Ruiz J, Watabe K, Pasche B, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E414-E415.

Stereotactic radiosurgery for multiple sclerosis associated trigeminal neuralgia [abstract]. Helis CA, McTyre E, Munley MT, Bourland JD, Cramer CK, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E512-E513.

Short pauses in thalamic deep brain stimulation promote tremor and neuronal bursting. Swan BD, Brocker DT, Hilliard JD, Tatter SB, Gross RE, Turner DA, Grill WM.. Clin Neurophysiol. 2016;127(2):1551-1559.

Ameliorating spinal cord injury in an animal model with mechanical tissue resuscitation. Zheng ZL, Morykwas MJ, Tatter S, Gordon S, McGee M, Green H, Argenta LC.. Neurosurgery. 2016;78(6):868-876.

Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward. Kishida KT, Saez I, Lohrenz T, Witcher MR, Laxton AW, Tatter SB, White JP, Ellis TL, Phillips PE, Montague PR... Proc Natl Acad Sci U S A. 2016;113(1):200-205.

Association between subthalamic nucleus deep brain stimulation and weight gain: results of a case-control study. Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS.. Clin Neurol Neurosurg. 2016;140():38-42.

Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after upfront radiosurgery alone for brain metastases [abstract]. Farris M, McTyre E, Hughes RT, Ayala-Peacock DN, Randolph DM II, Bourland JD, Tatter SB, Laxton AW, Watabe K, Ruiz J, Li W, Zhou X, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180.

Genomic predictors of imaging response and survival in glioblastoma [abstract]. Soike M, McTyre E, Holmes JA, Paulsson AK, Miller L, Lesser GJ, Strowd RE, Johnson A, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E121-E122.

Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm. Hughes RT, Black PJ, Page BR, Lucas JT, Qasem SA, Watabe K, Ruiz J, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Radiosurg SBRT. 2016;4(2):89-96.

Predictors of trigeminal nerve dysfunction following stereotactic radiosurgery for trigeminal neuralgia. Lucas JT, Huang AJ, Bourland JD, Laxton AW, Tatter SB, Chan MD.. J Radiosurg SBRT. 2016;4(2):117-123.

Laser ablation of recurrent malignant gliomas: current status and future perspective. Rodriguez A, Tatter SB.. Neurosurgery. 2016;79(Suppl 1):S35-S39.

Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Randolph DM II, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, Strowd R, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Clin Neurol Neurosurg. 2016;151():73-78.

Laser ablation after stereotactic radiosurgery (LAASR) - results of a multi-centered prospective study [abstract]. Chiang V, Dietrich J, Tatter S, Mohammadi A, Leuthardt E, Chamoun R, Judy K, Barnett G, Ahluwalia M.. Neuro Oncol. 2016;18(Suppl 6):31.

Upfront chemoradiotherapy in grade 2 low grade glioma, a single institution experience [abstract]. Wicks RT, Bandarage D, Mott RT, Strowd RE, Laxton AW, Tatter SB, Chan MD, Lesser GJ.. Neuro Oncol. 2016;18(Suppl 6):14.

Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB.. J Clin Neurosci. 2015;22(3):561-565.

Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD.. J Neurosurg. 2015;122(3):536-542.

Anaplastic ganglioglioma: a report of three cases and review of the literature. Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD.. J Neurooncol. 2015;123(1):171-177.

Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Neurosurgical management of brain metastases. Rodriguez A, Tatter SB.. Curr Probl Cancer. 2015;39(2):89-98.

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD.. Oncotarget. 2015;6(22):18945-55.

Neurosurgical techniques for disruption of the blood-brain barrier for glioblastoma treatment. Rodriguez A, Tatter SB, Debinski W.. Pharmaceutics. 2015;7(3):175-187.

Repeat radiosurgery for trigeminal neuralgia. Helis CA, Lucas JT Jr, Bourland JD, Chan MD, Tatter SB, Laxton AW.. Neurosurgery. 2015;77(5):755-761.

Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G.. J Clin Oncol. 2015;33(15 Suppl):e20669.

Factors that determine local control with gamma knife radiosurgery: the role of primary histology. Black PJ, Page BR, Lucas JT Jr, Hughes RT, Laxton AW, Tatter SB, Munley MT, Chan MD.. J Radiosurg SBRT. 2015;3(4):281-286.

Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Neurooncol. 2015;124(3):447-453.

A multi-institutional analysis of patients treated with stereotactic radiosurgery for brain metastases from radioresistant histologies [abstract]. Smith CA, McTyre E, Isom S, Kennedy VE, Luo G, Morales-Paliza M, Hinson W, Cmelak AJ, Tatter SB, Chan MD, Attia A.. Int J Radiat Oncol Biol Phys. 2015;93(3):E87-E88.

A competing risks analysis assessing predictors of neurologic and non-neurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy [abstract]. McTyre E, Johnson A, Ruiz J, Isom S, Lucas JT Jr, Hinson W, Watabe K, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S176.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide [abstract]. McTyre E, Lucas JT Jr, Helis C, Farris M, Houseknecht K, Mott R, Laxton AW, Tatter SB, Lesser GJ, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E108.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Neurosurgery

Clinical Interests

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor
Stephen B. Tatter, M.D., Ph.D.

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery

Doctor Rating

4.7 out of 5

Stephen B. Tatter, M.D., Ph.D.193 Ratings
15 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
4.2



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

10/30/2017

Dr. Tatter is very professional and very caring; the best!

9/29/2017

Dr. Tatter and Rich Lowder are awesome. I am in great hands. Could not be more satisfied with my care from the entire staff at NCBH.

9/12/2017

Dr. Tatter explained my cavernoma to me very well, and gave me peace of mind about recurrence rate and healing time.

8/8/2017

Dr. Tatter is an excellent medical care provider and I would gladly and highly recommend him to others. His PA, Rich is also an excellent assistant, I'm very pleased with Dr. Tatter's medical team abd practice.

8/7/2017

I tell all my friends that if they need more than their family doctor can provide to have them refer them to you. . I have already advised a friend about her knee replacement and the effects on her other knee ,that she may need to get referred to your specialists.

7/12/2017

good

7/6/2017

Very reassuring.

6/26/2017

Dr. Tatter was extraordinarily kind, patient and helpful in explaining an invasive procedure.

6/24/2017

Dr. Tatter was awesome. Josh has a very long, difficult medical history and seeing a new provider is very time consuming and difficult. Dr. Tatter had obviously reviewed Josh's medical history because he was very aware of current and past problems he's had. He was very easy to talk with and very friendly.

4/6/2017

Dr Tatter is unquestionably the most brilliant person I've ever met. I continue to have endless trust in his care.

4/4/2017

medical staff was excellent

3/14/2017

Dr. Tatter is terrific - professional and caring!

2/28/2017

*Dr. Tatter is an awesome dr. He is concerned about my problem and I'm confident that he will do what's best for me.

2/15/2017

Dr Tatter is top-notch. Very knowledgeable , kind and friendly

1/3/2017

I will highly recommend the neuro services that Wake Forrest Medical Center delivers.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.